- Japan（Japanese / English）
- Global
- MBL TOP
- MBL site search
Close
This site is for customers in Japan.
Customers in other regions, please go to Global page.
HOME > Discontinued products list
Product（9890）
Kits（371）
Proteins（113）
Peptide（7）
Enzymes（146）
ISH Probe（165）
RNAscope（127）
Vectors（60）
Reagents（193）
Tissue arrays（155）
Suger Chains（71）
Lectins（16）
Cell strains（2）
Blocking Peptides（638）
Others（25）
| Code No. | Product | Discontinued date | Manufacturer |
|---|---|---|---|
| CY-M1014 | Anti-Phospho-Rb (Thr356) mAb | 2019/03/31 | MBL |
| CY-M1017 | Anti-Phospho-G-substrate (Thr68/119) mAb | 2019/03/31 | MBL |
| CY-M1018 | Anti-Phospho-Cdc25C (Ser216) mAb | 2019/03/31 | MBL |
| CY-M1019 | Anti-Phospho-LSP1 (Ser204) mAb | 2019/03/31 | MBL |
| CY-M1022 | Anti-Phospho-p53 Ser46 mAb | 2019/03/31 | MBL |
| CY-M1025 | Anti-Phospho-AKTide-2T mAb | 2019/03/31 | MBL |
| CY-M1030 | Anti-Lats2 (Human) mAb | 2019/03/31 | MBL |
| CY-M1031 | Anti-GSK-3α mAb | 2019/03/31 | MBL |
| CY-M1034 | Anti-Paraoxonase-1 (Human) mAb | 2019/03/31 | MBL |
| CY-M1036 | Anti-S100A10 mAb | 2019/03/31 | MBL |
| CY-M1039 | Anti-S100A3 (Human) mAb | 2019/03/31 | MBL |
| CY-M1040 | Anti-UCHL1/PARK5 (Human) mAb | 2019/03/31 | MBL |
| CY-P1011 | Anti-HDAC1 (Histone Deacetylase 1) pAb | 2019/03/31 | MBL |
| CY-P1015 | Anti-Phospho-Histone-H2A.X (Ser139) pAb | 2019/03/31 | MBL |
| CY-P1019 | Anti-ANGPTL3 (Angiopoietin-Like 3) pAb | 2019/03/31 | MBL |
| CY-P1021 | Anti-ANGPTL4 (Angiopoietin-Like 4) pAb | 2019/03/31 | MBL |
| CY-P1022 | Anti-ANGPTL4 (Angiopoietin-Like 4) pAb | 2019/03/31 | MBL |
| CY-P1026 | Anti-S100A4/p9Ka pAb | 2019/03/31 | MBL |
| CY-P1032 | Anti-nm23-H1 pAb | 2019/03/31 | MBL |
| CY-P1033 | Anti-S100A10 pAb | 2019/03/31 | MBL |
| CY-P1035 | Anti-Osteopontin pAb | 2019/03/31 | MBL |
| CY-P1036 | Anti-AIM (CD5L/Spα) (Human) pAb | 2019/03/31 | MBL |
| D022-3 | Anti-CD130 (gp130/IL-6Rβ) mAb | 2019/03/31 | MBL |
| D023-3 | Anti-CD130 (gp130/IL-6Rβ) (Mouse) mAb | 2019/03/31 | MBL |
| D023-5 | Anti-CD130 (gp130/IL-6Rβ) (Mouse) mAb-PE | 2019/03/31 | MBL |
| D026-3 | Anti-Fas (CD95) (Mouse) mAb | 2019/03/31 | MBL |
| D027-3 | Anti-Fas (CD95) (Mouse) mAb | 2019/03/31 | MBL |
| D038-5 | Anti-Bcl-2 mAb-PE | 2019/03/31 | MBL |
| D041-3 | Anti-Fas Ligand (CD178) (Human) mAb | 2019/03/31 | MBL |
| D041-4 | Anti-Fas Ligand (CD178) (Human) mAb-FITC | 2019/03/31 | MBL |
| D041-5 | Anti-Fas Ligand (CD178) (Human) mAb-PE | 2019/03/31 | MBL |
| D041-6 | Anti-Fas Ligand (CD178) (Human) mAb-Biotin | 2019/03/31 | MBL |
| D042-3 | Anti-Fas Ligand (CD178) (Human) mAb | 2019/03/31 | MBL |
| D049-3 | Anti-RECK (Human) mAb | 2019/03/31 | MBL |
| D050-5 | Anti-CD29 (Integrin β1) (Human) mAb-PE | 2019/03/31 | MBL |
| D051-3 | Anti-CD154 (CD40 Ligand) (Human) mAb | 2019/03/31 | MBL |
| D051-4 | Anti-CD154 (CD40 Ligand) (Human) mAb-FITC | 2019/03/31 | MBL |
| D052-3 | Anti-Sca-1 (Mouse) mAb | 2019/03/31 | MBL |
| D052-5 | Anti-Sca-1 (Mouse) mAb-PE | 2019/03/31 | MBL |
| D052-6 | Anti-Sca-1 (Mouse) mAb-Biotin | 2019/03/31 | MBL |
| D053-3 | Anti-Mesothelin (Mouse) mAb | 2019/03/31 | MBL |
| D053-5 | Anti-Mesothelin (Mouse) mAb-PE | 2019/03/31 | MBL |
| D056-3 | Anti-CD43 (Human) mAb | 2019/03/31 | MBL |
| D056-4 | Anti-CD43 (Human) mAb-FITC | 2019/03/31 | MBL |
| D056-5 | Anti-CD43 (Human) mAb-PE | 2019/03/31 | MBL |
| D059-3 | Anti-OSMR (Oncostatin M Receptor) (Mouse) mAb | 2019/03/31 | MBL |
| D061-3 | Anti-FAK mAb | 2019/03/31 | MBL |
| D061-A48 | Anti-FAK (Human) mAb-Alexa Fluor® 488 | 2019/03/31 | MBL |
| D061-A59 | Anti-FAK (Human) mAb-Alexa Fluor® 594 | 2019/03/31 | MBL |
| D062-3 | Anti-TER-119 (Mouse) mAb | 2019/03/31 | MBL |
| D062-4 | Anti-TER-119 (Mouse) mAb-FITC | 2019/03/31 | MBL |
| D062-5 | Anti-TER-119 (Mouse) mAb-PE | 2019/03/31 | MBL |
| D063-3 | Anti-CD191 (CCR1) (Human) mAb | 2019/03/31 | MBL |
| D063-5 | Anti-CD191 (CCR1) (Human) mAb-PE | 2019/03/31 | MBL |
| D064-3 | Anti-CD4 (Human) mAb | 2019/03/31 | MBL |
| D064-4 | Anti-CD4 (Human) mAb-FITC | 2019/03/31 | MBL |
| D072-3 | Anti-Podocalyxin (PCLP1) (Mouse) mAb | 2019/03/31 | MBL |
| D072-4 | Anti-Podocalyxin (PCLP1) (Mouse) mAb-FITC | 2019/03/31 | MBL |
| D072-5 | Anti-Podocalyxin (PCLP1) (Mouse) mAb-PE | 2019/03/31 | MBL |
| D072-6 | Anti-Podocalyxin (PCLP1) (Mouse) mAb-Biotin | 2019/03/31 | MBL |
| D074-3 | Anti-CD197 (CCR7) (Human) mAb | 2019/03/31 | MBL |
| D076-3S | Anti-Phosphorylated Vimentin (Ser55) mAb | 2019/03/31 | MBL |
| D077-3 | Anti-TLR4 (CD284) (Human) mAb | 2019/03/31 | MBL |
| D077-4 | Anti-TLR4 (CD284) (Human) mAb-FITC | 2019/03/31 | MBL |
| D077-5 | Anti-TLR4 (CD284) (Human) mAb-PE | 2019/03/31 | MBL |
| D079-4 | Anti-TLR4-MD-2 complex (Mouse) mAb-FITC | 2019/03/31 | MBL |
| D079-5 | Anti-TLR4-MD-2 complex (Mouse) mAb-PE | 2019/03/31 | MBL |
| D080-3 | Anti-RP105 (CD180) (Human) mAb | 2019/03/31 | MBL |
| D080-5 | Anti-CD180 (RP105) (Human) mAb-PE | 2019/03/31 | MBL |
| D081-1 | Anti-DNA Topoisomerase IIα (Human) mAb | 2019/03/31 | MBL |
| D081-1H | Anti-DNA Topoisomerase IIα (Human) mAb | 2019/03/31 | MBL |
| D081-1S | Anti-DNA Topoisomerase IIα (Human) mAb | 2019/03/31 | MBL |
| D082-3 | Anti-CD151 (SFA-1) (Human) mAb | 2019/03/31 | MBL |
| D082-5 | Anti-CD151 (SFA-1) (Human) mAb-PE | 2019/03/31 | MBL |
| D084-3 | Anti-CD113 (Nectin-3) (Mouse) mAb | 2019/03/31 | MBL |
| D085-3 | Anti-CD193 (CCR3) (Human) mAb | 2019/03/31 | MBL |
| D085-4 | Anti-CD193 (CCR3) (Human) mAb-FITC | 2019/03/31 | MBL |
| D085-5 | Anti-CD193 (CCR3) (Human) mAb-PE | 2019/03/31 | MBL |
| D088-3 | Anti-LECT2 (Human) mAb | 2019/03/31 | MBL |
| D089-3 | Anti-LECT2 (Human) mAb | 2019/03/31 | MBL |
| D090-3 | Anti-HMGB1/2 (HMG1/2) mAb | 2019/03/31 | MBL |
| D091-6 | Anti-CTLA-4 (CD152) mAb-Biotin | 2019/03/31 | MBL |
| D093-3S | Anti-Phosphorylated Vimentin (Ser71) mAb | 2019/03/31 | MBL |
| D094-3 | Anti-Phosphorylated Vimentin (Ser38) mAb | 2019/03/31 | MBL |
| D094-3S | Anti-Phosphorylated Vimentin (Ser38) mAb | 2019/03/31 | MBL |
| D095-3S | Anti-Phosphorylated Vimentin (Ser82) mAb | 2019/03/31 | MBL |
| D096-3 | Anti-Phosphorylated Vimentin (Ser6) mAb | 2019/03/31 | MBL |
| D096-3S | Anti-Phosphorylated Vimentin (Ser6) mAb | 2019/03/31 | MBL |
| D097-3S | Anti-GFAP (Glial Fibrillary Acidic Protein) mAb | 2019/03/31 | MBL |
| D098-3 | Anti-Phosphorylated GFAP (Thr7) mAb | 2019/03/31 | MBL |
| D098-3S | Anti-Phosphorylated GFAP (Thr7) mAb | 2019/03/31 | MBL |
| D099-3 | Anti-Phosphorylated Vimentin (Ser33) mAb | 2019/03/31 | MBL |
| D099-3S | Anti-Phosphorylated Vimentin (Ser33) mAb | 2019/03/31 | MBL |
| D111-3 | Anti-IFN-α (Human) mAb | 2019/03/31 | MBL |
| D113-3 | Anti-TNF-α (Human) mAb | 2019/03/31 | MBL |
| D114-3 | Anti-TNF-β (Lymphotoxin) (Human) mAb | 2019/03/31 | MBL |
| D121-3 | Anti-Phosphorylated GFAP (Ser13) mAb | 2019/03/31 | MBL |
| D122-3 | Anti-Phosphorylated Vimentin (Ser50) mAb | 2019/03/31 | MBL |
| D122-3S | Anti-Phosphorylated Vimentin (Ser50) mAb | 2019/03/31 | MBL |
| D124-3 | Anti-CD195 (CCR5) (Human) mAb | 2019/03/31 | MBL |